BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laser capture microdissection
,
Lipopolysaccharide
,
rs4950928
,
GATA1
,
Ischemia
,
Liver
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
transitional cell carcinomas
Summary
General Info
Curated Studies
Most Correlated Studies
Gene expression profiles of poorly differentiated, moderately differentiated and metastatic cancers
A375, A549, H3122, PC-9, NCI-N87 and RT-112 cells treated with THZ1 and/or tyrosine kinase inhibitor
Urothelial bladder carcinoma cells with KDM6A mutation and treatment with EZH2 inhibitor GSK343
Bladder cancer subsets expression profile analysis
RPE-1 hTERT and UM-UC-3 cells with RAS mutation treated with prexasertib & gemcitabine
Explore Curated Studies Results
Literature
Most Relevant Literature
The assessed value of 64 slice spiral CT perfusion imaging in laryngeal squamous cell carcinoma afte…
Absolute CT perfusion parameter values after the neoadjuvant chemoradiotherapy of the squamous cell …
Investigation of Renal Cell Carcinoma by Contrast-Enhanced Ultrasound- Predictive Value of Time Inte…
Change of Swallowing in Patients With Head and Neck Cancer After Concurrent Chemoradiotherapy.
Quantitative Analysis of Hepatic Microcirculation in Rabbits After Liver Ischemia-Reperfusion Injury…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel
A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder
CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood
Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract …
Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the Bladder
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ